Business

Australis To Host Conference Call

Australis To Host Conference Call.

articleAustralis Capital Inc.January 6, 20214/company/australis-capital-inc/news/australis-to-host-conference-call
Australis To Host Conference Call

About this update from Australis Capital Inc.

[{"type":"text","content":"\n\n\n\nAustralis To Host Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nAustralis To Host Conference Call\nPR Newswire\nLAS VEGAS, Jan. 6, 2021\n\n\n\nCompany Will Host Conference Call Thursday January 7, 2021 at 12pm ET\n LAS VEGAS, Jan. 6, 2021 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (\"AUSA\" or the \"Company\") is hosting a conference call tomorrow, January 7, 2021 at 12:00pm ET to discuss the announced intended transactions in regards Green Therapeutics and ALPS.\n\n \n \n \n \n \n \n\n \n \nConference call details\nConference Call Participant Numbers\nConfirmation #:\n87780553\nLocal:\n416-764-8659\nNorth American Toll Free: \n1-888-664-6392 \nWebcast URL:\nhttp://bitly.ws/b23 \nAbout Australis Capital Inc.\nAUSA is implementing a capital light growth strategy towards establishing a highly competitive and profitable MSO in the U.S. and global cannabis markets. AUSA's business lines and assets include investments in Cocoon, Body and Mind Inc., Quality Green, Folium Biosciences, and land assets in Washington. AUSA is currently working towards the closing of a transaction whereby it will acquire 100% of the membership interest in Green Therapeutics LLC, an award winning MSO with operations in Nevada, Missouri and Oklahoma. Furthermore, the Company is working towards completing the acquisition of ALPS, the world's premier design, construction management, commissioning and post commissioning consultancy for horticultural crops, such as cannabis, fruits, vegetables, mushrooms and algae. Through GT and ALPS, the Company believes it will be able to secure low cost access to cannabis biomass to fuel the scale up of its award winning brands across the U.S. and global cannabis markets.\nThe Company's common shares trade on the...

More updates from Australis Capital Inc.